These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9698740)

  • 21. Reversible parkinsonian syndrome in systemic and brain vasculitis.
    Fabiani G; Teive HA; Germiniani FM; Sá DS; Werneck LC
    Mov Disord; 2002 May; 17(3):601-4. PubMed ID: 12112215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A retrospective analysis of treatment outcomes in patients with hepatitis C related systemic vasculitis receiving intravenous methylprednisolone and cyclophosphamide.
    Shahin AA; El Desouky SM; Zayed HS
    Clin Rheumatol; 2011 May; 30(5):607-14. PubMed ID: 20924628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vasculitis of the nervous system in infectious diseases].
    Jacobi C; Lenhard T; Meyding-Lamadé U
    Nervenarzt; 2010 Feb; 81(2):172-80. PubMed ID: 20101491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Idiopathic hypocomplementemic urticarial vasculitis-linked neuropathy.
    Filosto M; Cavallaro T; Pasolini G; Broglio L; Tentorio M; Cotelli M; Ferrari S; Padovani A
    J Neurol Sci; 2009 Sep; 284(1-2):179-81. PubMed ID: 19375087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends of anticardiolipin antibodies after low-dose methylprednisolone and cyclophosphamide treatment of systemic lupus erythematosus.
    Lavalle-Graef A; Villegas-Acosta L; Lavalle C
    Arch Med Res; 2004; 35(5):421-7. PubMed ID: 15610913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steroid-resistant peripheral neuropathy in a child: a rare finding in immunoglobulin a vasculitis.
    Aydın F; Kurt T; Ünlü E; Tekin ZE; Çelikel E; Acar BÇ
    Turk J Pediatr; 2022; 64(3):576-579. PubMed ID: 35899572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testicular involvement in rheumatoid vasculitis.
    Mayer DF; Matteson EL
    Clin Exp Rheumatol; 2004; 22(6 Suppl 36):S62-4. PubMed ID: 15675137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide.
    Martin-Suarez I; D'Cruz D; Mansoor M; Fernandes AP; Khamashta MA; Hughes GR
    Ann Rheum Dis; 1997 Aug; 56(8):481-7. PubMed ID: 9306871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial fibrillation associated with systemic lupus erythematosus and use of methylprednisolone.
    Aslam AK; Vasavada BC; Sacchi TJ; Khan IA
    Am J Ther; 2001; 8(4):303-5. PubMed ID: 11441330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monocular Oculomotor Nerve Disorder Manifesting as Cranial Neuropathy in Systemic Lupus Erythematosus.
    Nakamagoe K; Yanagiha H; Miyake Z; Kondo Y; Hiyama T; Ishii A; Kaji Y; Oshika T; Sumida T; Tamaoka A
    Intern Med; 2018 Dec; 57(23):3445-3449. PubMed ID: 29984768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-systemic vasculitic neuropathy: single-center follow-up of 60 patients.
    Üçeyler N; Geng A; Reiners K; Toyka KV; Sommer C
    J Neurol; 2015 Sep; 262(9):2092-100. PubMed ID: 26092519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple mononeuropathy as the initial presentation of systemic lupus erythematosus--nerve biopsy and response to plasma exchange.
    Hughes RA; Cameron JS; Hall SM; Heaton J; Payan J; Teoh R
    J Neurol; 1982; 228(4):239-47. PubMed ID: 6188811
    [No Abstract]   [Full Text] [Related]  

  • 33. Neurological complications of vasculitis.
    Moore PM; Cupps TR
    Ann Neurol; 1983 Aug; 14(2):155-67. PubMed ID: 6137994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging evidence of successful multiple immunosuppressive treatment of cerebral involvement in Wegener's granulomatosis.
    Riccieri V; Spadaro A; Parisi G; Benfari G; Trasimeni G; Taccari MD; Valesini G
    Clin Exp Rheumatol; 2002; 20(4):578-9. PubMed ID: 12180438
    [No Abstract]   [Full Text] [Related]  

  • 35. Reversal of progressive necrotizing vasculitis with intravenous pulse cyclophosphamide and methylprednisolone.
    Fort JG; Abruzzo JL
    Arthritis Rheum; 1988 Sep; 31(9):1194-8. PubMed ID: 3422017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic dilemmas in the care of a human immunodeficiency virus-infected patient with vasculitis: case report.
    O'Grady NP; Sears CL
    Clin Infect Dis; 1996 Sep; 23(3):659-61. PubMed ID: 8879811
    [No Abstract]   [Full Text] [Related]  

  • 37. Intravenous pulses of methylprednisolone for systemic lupus erythematosus.
    Badsha H; Edwards CJ
    Semin Arthritis Rheum; 2003 Jun; 32(6):370-7. PubMed ID: 12833245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vasculitic neuropathy: novel classification, diagnosis and treatment].
    Kanda T
    Rinsho Shinkeigaku; 2014; 54(12):1050-2. PubMed ID: 25672706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia.
    Smith DR; Balashov KE; Hafler DA; Khoury SJ; Weiner HL
    Ann Neurol; 1997 Sep; 42(3):313-8. PubMed ID: 9307252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose pulse methylprednisolone for systemic lupus erythematosus flares is efficacious and has a decreased risk of infectious complications.
    Badsha H; Kong KO; Lian TY; Chan SP; Edwards CJ; Chng HH
    Lupus; 2002; 11(8):508-13. PubMed ID: 12220105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.